| | PRESS RELEASE First Clinical Trial to Demonstrate Colesevelam HCl Plus Stable Oral Antidiabetic Medication Improves ... (Site not responding. Last check: 2007-10-30) |
 | | PARSIPPANY, NJ -- (MARKET WIRE) -- June 10, 2006 -- The first data to demonstrate the effect of WelChol® (colesevelam hydrochloride) on glucose lowering was presented today at The American Diabetes Association's (ADA) 66th Annual Scientific Sessions in Washington, DC. |
 | | The Glucose Lowering Effect Of WelChol Study (GLOWS) examined the ability of a bile acid sequestrant, colesevelam HCl, to improve glycemic control in addition to a patient's current oral antidiabetic therapy. |
 | | Addition of WelChol did not cause weight gain, a typical side effect of glucose-lowering therapies, and did not cause increased incidence of hypoglycemia. |
| www.marketwire.com /mw/release_html_b1?release_id=134706&tsource=3 (1024 words) |